139 related articles for article (PubMed ID: 21122666)
1. Report of simultaneous acute pancreatitis and acute hepatitis in a patient taking ezetimibe/simvastatin.
Van Woerkom RC; Adler DG
J Clin Lipidol; 2010; 4(4):314-5. PubMed ID: 21122666
[No Abstract] [Full Text] [Related]
2. A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment.
Antonopoulos S; Mikros S; Kokkoris S; Protopsaltis J; Filioti K; Karamanolis D; Giannoulis G
JOP; 2005 May; 6(3):264-8. PubMed ID: 15883478
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin + ezetimibe: a combination with no proven advantages.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
[No Abstract] [Full Text] [Related]
4. Ezetimibe + simvastatin (Merck/Schering-Plough).
Flores NA
Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
[TBL] [Abstract][Full Text] [Related]
5. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
Aalbers J
Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
[No Abstract] [Full Text] [Related]
6. [On the current debate on lowering LDL cholesterol with ezetimibe].
Breuer HW
Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
[No Abstract] [Full Text] [Related]
7. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
8. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
9. Ezetimibe/simvastatin.
Montecucco F; Quercioli A; Mach F
Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe and recent clinical trials: a look on the bright side.
Ahmed MH
Expert Opin Drug Saf; 2010 Jul; 9(4):511-4. PubMed ID: 20377476
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe and cancer--an uncertain association.
Drazen JM; D'Agostino RB; Ware JH; Morrissey S; Curfman GD
N Engl J Med; 2008 Sep; 359(13):1398-9. PubMed ID: 18765434
[No Abstract] [Full Text] [Related]
13. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
14. Premature release of data from clinical trials of ezetimibe.
Califf RM; Harrington RA; Blazing MA
N Engl J Med; 2009 Aug; 361(7):712-7. PubMed ID: 19675335
[No Abstract] [Full Text] [Related]
15. Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe.
van Heyningen C
Ann Clin Biochem; 2005 Sep; 42(Pt 5):402-4. PubMed ID: 16168199
[TBL] [Abstract][Full Text] [Related]
16. In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.
Med Lett Drugs Ther; 2012 Jan; 54(1381):4. PubMed ID: 22233589
[No Abstract] [Full Text] [Related]
17. [How sure is the combined lipid lowering?].
Schäfer J
MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
[No Abstract] [Full Text] [Related]
18. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
[TBL] [Abstract][Full Text] [Related]
19. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Skjaerpe T; Wachtell K; Willenheimer R;
N Engl J Med; 2008 Sep; 359(13):1343-56. PubMed ID: 18765433
[TBL] [Abstract][Full Text] [Related]
20. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]